Construction of a functional transporter analysis system using MDR1 knockdown Caco-2 cells.

Area of Science:

• Pharmacology
• Cell Biology
• Drug Discovery

Background:

• P-glycoprotein (P-gp) limits oral drug bioavailability by actively transporting drugs out of intestinal cells.
• Current in vitro models using P-gp inhibitors may affect other cellular functions.
• A more specific method is needed to evaluate P-gp's role in drug absorption.

Purpose of the Study:

• To develop and validate a novel in vitro model for assessing intestinal drug absorption.
• To create Caco-2 cells with specifically inhibited Multidrug Resistance 1 gene (MDR1) expression.
• To establish a reliable system for evaluating drug absorption influenced by P-gp.

Main Methods:

• Utilized RNA interference (RNAi) technology with siRNA libraries and single siRNAs.
• Constructed stable MDR1 knockdown Caco-2 cell lines using a tRNA(val)-shRNA expression vector.
• Performed transcellular transport studies using digoxin to assess P-gp function.

Main Results:

• Successfully reduced MDR1 gene expression at both mRNA and protein levels in engineered Caco-2 cells.
• Demonstrated complete suppression of P-gp function in these cells, comparable to verapamil treatment.
• Validated the efficacy of the MDR1 knockdown model in inhibiting P-gp activity.

Conclusions:

• Achieved successful construction of MDR1 stable knockdown Caco-2 cells via RNAi.
• This novel cell line provides a superior in vitro system for evaluating intestinal drug absorption.
• Enables the development of a selection system for candidate drugs with enhanced absorption profiles.